ALBIREO PHARMA INC - COMMON STOCK (ALBO)

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COMMON STOCK
Total 13F shares
16,671,414
Share change
+1,017,854
Total reported value
$625,315,261
Put/Call ratio
227%
Price per share
$37.51
Number of holders
105
Value change
+$41,708,812
Number of buys
64
Number of sells
50

Institutional Holders of ALBIREO PHARMA INC - COMMON STOCK (ALBO) as of Q4 2020

As of 31 Dec 2020, ALBIREO PHARMA INC - COMMON STOCK (ALBO) was held by 105 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,671,414 shares. The largest 10 holders included FEDERATED HERMES, INC., PERCEPTIVE ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, ArrowMark Colorado Holdings LLC, Artal Group S.A., MARSHALL WACE, LLP, Chicago Capital, LLC, and Cormorant Asset Management, LP. This page lists 105 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.